Suppr超能文献

人类骨髓移植后干扰素产生恢复的动力学

Kinetics of restoration of interferon production after bone marrow transplantation in man.

作者信息

Koscielniak E, Bruchelt G, Treuner J, Uchanska-Ziegler B, Dopfer R, Vallbracht A, Niethammer D

机构信息

Department of Hematology, Children's Hospital, Tübingen, GFR.

出版信息

Bone Marrow Transplant. 1987 Apr;1(4):379-87.

PMID:2458787
Abstract

Peripheral blood mononuclear cells (PBMC) from 21 patients after bone marrow transplantation (BMT) were studied for their capacity to produce interferon (IFN) in vitro. The basal and IFN-stimulated 2-5 A synthetase activity was also investigated as a marker of the cells' ability to respond to exogenous IFN. All but one patients received cyclosporin A as a prophylaxis against graft-versus-host disease (GVHD). GVHD was diagnosed in three patients. IFN production in response to stimulation with phytohemagglutinin or poly I:C was not detectable in most patients without GVHD until 7 months after grafting. However, in a proportion of recipients without GVHD, studied early after BMT, transient normal IFN production was observed. In contrast to patients without GVHD, PBMC from patients with GVHD produced stable high levels of IFN when stimulated in vitro. The impairment of IFN production did not correlate with conditioning regimens, infection, plasma cyclosporin levels or the lymphocytes' blastogenic response to the mitogens. Addition of interleukin-2 (IL-2) to culture medium of fresh unresponsive PBMC restored only partially the defective IFN production. Similarly, T-cell lines propagated in IL-2 conditioned medium, from unresponsive PBMC, produced low levels of IFN gamma when stimulated with PHA. The basal activity of 2-5 A synthetase in PBMC from patients without GVHD could not be stimulated, during the first 3 months after BMT, by the cultivation of cells with IFN alpha.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对21例骨髓移植(BMT)后患者的外周血单个核细胞(PBMC)进行体外产生干扰素(IFN)能力的研究。还研究了基础及IFN刺激后的2-5A合成酶活性,作为细胞对外源性IFN反应能力的标志物。除1例患者外,所有患者均接受环孢素A预防移植物抗宿主病(GVHD)。3例患者被诊断为GVHD。在大多数无GVHD的患者中,移植后7个月内,用植物血凝素或聚肌胞苷酸刺激时未检测到IFN产生。然而,在一部分BMT后早期研究的无GVHD受者中,观察到短暂的正常IFN产生。与无GVHD的患者相反,体外刺激时,GVHD患者的PBMC产生稳定的高水平IFN。IFN产生受损与预处理方案、感染、血浆环孢素水平或淋巴细胞对丝裂原的增殖反应无关。向新鲜无反应性PBMC的培养基中添加白细胞介素-2(IL-2)仅部分恢复了缺陷的IFN产生。同样,从不反应性PBMC在IL-2条件培养基中培养的T细胞系,用PHA刺激时产生低水平的IFNγ。在BMT后的前3个月内,无GVHD患者PBMC中2-5A合成酶的基础活性不能通过用IFNα培养细胞来刺激。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验